Metoprolol
Alternative Names: Lopressor
Metoprolol is a beta-blocker commonly used to control heart rate in atrial fibrillation. It works by slowing conduction through the AV node and reducing the effects of adrenaline on the heart, which helps lower a rapid ventricular response. It can be given intravenously for acute rate control in the hospital or orally for ongoing management. Caution is needed in patients with low blood pressure, heart failure, or very slow heart rates.
Treatment Type: Prescription Medication
Treatment Class: Beta Blocker
Treatment Modality: Intravenous (IV), Oral
Review Summary
Based on the single review provided, Metoprolol (Lopressor) appears to be a moderately effective treatment for atrial fibrillation, specifically for rate control. The reviewer suggests it is recommended but may be less effective compared to calcium channel blockers, and is typically used as an alternative, especially for patients already on beta blockers. However, with only one review, a definitive assessment of its overall effectiveness is limited.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
5.0
AI Summary of User Experiences
Not medical advice.
Based on the single review provided, Metoprolol (Lopressor) appears to be a moderately effective treatment for atrial fibrillation, specifically for rate control. The reviewer suggests it is recommended but may be less effective compared to calcium channel blockers, and is typically used as an alternative, especially for patients already on beta blockers. However, with only one review, a definitive assessment of its overall effectiveness is limited.
Reviews
Filter by reviewer type Pro